These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 6820888

  • 1. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 2. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 3. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 4. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y, Hirata H, Sakamoto K, Sato M, Morikage T, Maruyama M, Sasaki K, Yano S.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
    [Abstract] [Full Text] [Related]

  • 5. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
    Sugiyama M, Morisaki N, Konishi K, Go K, Sugita M, Nakai Y.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
    Nanjo M, Saito M, Aonuma E, Fujimura H, Nakamura T, Aso H, Yoshie O, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
    [Abstract] [Full Text] [Related]

  • 7. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
    Ujiie T.
    Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
    [Abstract] [Full Text] [Related]

  • 8. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D.
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [Abstract] [Full Text] [Related]

  • 9. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 10. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H, Kasahara T, Minato N, Hamuro J, Miyata M, Morioka Y.
    J Natl Cancer Inst; 1982 Oct 15; 69(4):807-12. PubMed ID: 6181282
    [Abstract] [Full Text] [Related]

  • 11. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec 20; 24(11):2546-55. PubMed ID: 2614190
    [Abstract] [Full Text] [Related]

  • 12. [Characterization and bioactivity of interferon induced by Streptococcus faecalis preparation, TH69].
    Yamaguchi T, Saito M, Kuroda Y, Ebina T, Ishida N, Hoshino F, Kawade Y.
    Gan To Kagaku Ryoho; 1982 Sep 20; 9(9):1609-16. PubMed ID: 6820922
    [Abstract] [Full Text] [Related]

  • 13. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun 20; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T, Okamoto M, Ohe G, Furuichi S, Nishikawa H, Uddin Ahmed S, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    Int Immunopharmacol; 2003 May 20; 3(5):643-55. PubMed ID: 12757734
    [Abstract] [Full Text] [Related]

  • 15. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
    Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA.
    J Immunol; 1997 Jun 15; 158(12):5619-26. PubMed ID: 9190909
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
    Sato M, Kaji R, Urata M, Yoshida H, Yanagawa T, Miyamoto K, Azuma M, Furumoto N, Saito M.
    J Biol Response Mod; 1988 Apr 15; 7(2):212-28. PubMed ID: 3361352
    [Abstract] [Full Text] [Related]

  • 17. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection].
    Lei H, Cao X, Yu Y.
    Zhonghua Zhong Liu Za Zhi; 1998 May 15; 20(3):174-7. PubMed ID: 10920999
    [Abstract] [Full Text] [Related]

  • 18. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K, Ichimura O, Mitsuno T, Osawa T.
    J Immunol; 1985 Feb 15; 134(2):1039-47. PubMed ID: 2578148
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M, Takashige K, Furuyashiki M, Yoshidome K, Sano R, Kawamura Y, Ijichi S, Morioka H, Koide H, Oku N, Moriya Y, Kusumoto S, Suda Y.
    Int Immunopharmacol; 2008 Jan 15; 8(1):12-9. PubMed ID: 18068095
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H, Reynolds CW.
    J Natl Cancer Inst; 1987 Nov 15; 79(5):1019-24. PubMed ID: 3500354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.